National Institute of Diabetes and Digestive and Kidney Diseases
Schedules
TAFS: 075-0884 /X - National Institute of Diabetes and Digestive and Kidney Diseases
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | ME | Mandatory Expected - Unob Bal: Brought forward, October 1 | $263,385,000.00 | See footnotes below |
| Footnotes for line 1000 (ME): | B1: A total unobligated balance of $263,000,000 will be brought forward to FY 2022 from the special diabetes program. In addition, a total unobligated balance of $385,000 for Research resources will be brought forward to FY 2022. | |||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $500,000.00 | ||
| 1200 | BA: Mand: Appropriation | $150,000,000.00 | See footnotes below | |
| Footnotes for line 1200: | B2: 134 STAT 2923 of PL 116-260, "Consolidated Appropriations Act, 2021." | |||
| 1230 | BA: Mand: New\Unob bal of approps perm reduced | -$8,550,000.00 | ||
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $100,000.00 | See footnotes below | |
| Footnotes for line 1840: | B3: Pursuant to P.L. 114-255, Section 2043 as authorized by Section 301 of the PHS Act, that amounts collected for research substances and organisms "shall be credited to the appropriations accounts that incurred the costs to make available the research substances and living organisms involved, and shall remain available until expended for carrying out activities under such accounts." | |||
| 1920 | Total budgetary resources avail (disc. and mand.) | $405,435,000.00 | ||
| 6001 | Category A -- 1st quarter | $485,000.00 | ||
| 6011 | Type 1 Diabetes | $404,950,000.00 | ||
| 6190 | Total budgetary resources available | $405,435,000.00 | See footnotes below | |
| Footnotes for line 6190: | A1: Details on attachments are not subject to 31 U.S.C. 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. A2: The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 U.S.C. 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| B1 | A total unobligated balance of $263,000,000 will be brought forward to FY 2022 from the special diabetes program. In addition, a total unobligated balance of $385,000 for Research resources will be brought forward to FY 2022. |
| B2 | 134 STAT 2923 of PL 116-260, "Consolidated Appropriations Act, 2021." |
| B3 | Pursuant to P.L. 114-255, Section 2043 as authorized by Section 301 of the PHS Act, that amounts collected for research substances and organisms "shall be credited to the appropriations accounts that incurred the costs to make available the research substances and living organisms involved, and shall remain available until expended for carrying out activities under such accounts." |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.